Fenofibrate
| Drug Category | Drug | IHD Dosing |
Administration Timing Around HD Session |
|---|---|---|---|
| Dyslipidemia Medications (Misc. ) | Fenofibrate | Not recommended | Administer Anytime During HD |
|
Molecular Weight (Da) | Excreted Unchanged (%) | Normal Half-Life (Hours) | ESRD Half-Life (Hours) | Plasma Protein Binding (%) | Volume of Distribution (L/kg) | Dialytic Plasma Clearance (ml/min) | % Dialyzed |
|---|---|---|---|---|---|---|---|
| 361 |
60 (as metabolites) |
20 | N/A | >99 | 0.43 | N/A | N/A |
References:
- DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL: http://www.drugbank.ca/drugs/DB01039
- Fenofibrate. In:Lexi-Drugs Online. Hudson (OH): Lexi-Comp, Inc,; [updated 04/23/12; accessed 04/23/12].